ArticleJAC-antimicrobial resistance2026

Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort.

Matilde Bognetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.